Immunoreactivity of recombinant human glandular kallikrein using monoclonal antibodies raised against prostate-specific antigen

Prostate

Volumn 31, Issue 2, 1997, Pages 84-90

  Eerola, Riitta ^a   Piironen, Timo ^a   Pettersson, Kim ^a   Lövgren, Janita ^b   Vehniäinen, Markus ^a   Lilja, Hans ^b   Dowell, Barry ^c   Lövgren, Timo ^a   Karp, Matti ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b LUND UNIVERSITY   (Sweden)

^c ABBOTT LABORATORIES   (United States)

Author keywords

cancer of the prostate; cDNA; diagnosis; Escherichia coli; hK2; protease; PSA

Indexed keywords

COMPLEMENTARY DNA; EPITOPE; KALLIKREIN; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; PROTEINASE; SIGNAL PEPTIDE;

AMINO ACID SEQUENCE; ANTIBODY AFFINITY; ARTICLE; CANCER DIAGNOSIS; ENZYME GLYCOSYLATION; ESCHERICHIA COLI; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANTIBODIES, MONOCLONAL; EPITOPES; ESCHERICHIA COLI; HUMANS; KALLIKREINS; PROSTATE-SPECIFIC ANTIGEN; RECOMBINANT PROTEINS; TISSUE KALLIKREINS;

EID: 0030949868     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970501)31:2<84::AID-PROS2>3.0.CO;2-H     Document Type: Article

References (27)

1. Lundwall Å: Characterization of the gene for prostate-specific antigen, a human glandular kallikrein. Biochem Biophys Res Commun 161:451-459, 1989.
2. Yu H, Diamandis EP, Monne M, Croce CM: Oral contraceptive-induced expression of prostate-specific antigen in the female breast. J Biol Chem 270:6615-6618, 1995.
3. Yu H, Diamandis EP, Levesque S, Asa S, Monne M, Croce CM: Expression of the prostate-specific antigen by a primary ovarian carcinoma. Cancer Res 55:1603-1606, 1995.
4. Yu H, Diamandis EP: Prostate-specific antigen immunoreactivity in amniotic fluid. Clin Chem 41:204-210, 1995.
5. 1-antichymotrypsin. Clin Chem 37:1618-1625, 1991.
6. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer. Cancer Res 51: 222-226, 1991.
7. 1-antichymotrypsin as an indicator of prostate cancer. J Urol 150:100-105, 1993.
8. Chapdelaine P, Paradis G, Tremblay RR, Dubé JY: High level expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen. FEBS Lett 236:205-208, 1988.
9. Henttu P, Lukkarinen O, Vihko P: Expression of the gene coding for human prostate-specific antigen and related hGK-1 in benign and malignant tumors of the human prostate. Int J Cancer 45:654-660, 1990.
10. Young CY, Andrews PE, Montgomery BT, Tindall DJ: Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein. Biochemistry 31:818-824, 1992.
11. Eerola R, Saviranta P, Lilja H, Pettersson K, Lövgren T, Karp M: Expression of prostate specific antigen on the surface of a filamentous phage. Biochem Biophys Res Commun 200:1346-1352, 1994.
12. 1-antichymotrypsin complex. Clin Chem 41:1480-1488, 1995.
13. Yanisch-Perron C, Vieira J, Messing J: Improved M13 phage cloning vectors and host strains: Nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119, 1985.
14. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N: Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350-1354, 1985.
15. Lundwall Å, Lilja H: Molecular cloning of human prostate specific antigen cDNA. FEBS Lett 214:317-322, 1987.
16. Hemminki A, Hoffren A-M, Takkinen K, Vehniäinen M, Mäkinen M-L, Pettersson K, Teleman O, Söderlund H, Teeri TT: Introduction of lysine residues on the light chain constant domain improves the labelling properties of a recombinant Fab fragment. Prot Eng 8:185-191, 1995.
17. Sambrook J, Fritsch EF, Maniatis T: "Molecular Cloning: A Laboratory Manual." 2nd Ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
18. Liljeström P, Garoff H: A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio/ Technology 9:1356-1361, 1991.
19. Lövgren J, Piironen T, Övermo C, Dowell B, Karp M, Pettersson K, Lilja H, Lundwall Å: Production of the recombinant PSA and hK2 and analysis of their immunologic cross-reactivity. Biochem Biophys Res Commun 213:888-895, 1995.
20. Christensson A, Laurell C-B, Lilja H: Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine protease inhibitors. Eur J Biochem 194:755-763, 1990.
21. Papsidero LD, Croghan GA, Wang MC, Kuriyama M, Johnson EA, Valenzuela LA, Chu TM: Monoclonal antibody (F5) to human prostate antigen. Hybridoma 2:139-147, 1983.
22. Scatchard G: The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660-672, 1949.
23. Riegman PHJ, Vlietstra RJ, van der Korput HAGM, Romijn JC, Trapman J: Identification and androgen-regulated expression of two major human glandular kallikrein-1 (hGK-1) mRNA species. Mol Cell Endocrinol 76:181-190, 1991.
24. Schaller J, Akiyama K, Tsuda R, Hara M, Marti T, Rickli EE: Isolation, characterization and amino acid sequence of gamma-seminoprotein, a glycoprotein from human seminal plasma. Eur J Biochem 170:111-120, 1987.
25. Schedlich LJ, Bennets B, Morris BJ: Primary structure of human glandular kallikrein gene. DNA 6:429-437, 1987.
26. Young CY-F, Andrews PE, Montgomery BT, Tindall DJ: Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein. Biochemistry 31:818-824, 1992.
27. Isomäki R, Herrala A, Kurkela R, Vihko P: A new prostatic protein: Human glandular kallikrein-1. In Adlercreuz H, Penttilä I, Tenhunen R, Weber T (eds): "Proceedings of the Laboratory Medicine '95." Eleventh IFCC European Congress of Clinical Chemistry, Tampere, Finland, July 2-7. Forssan Kirjapaino Oy, Forssa, Finland, 1995 (abst 726).